1. Home
  2. NEOG vs WVE Comparison

NEOG vs WVE Comparison

Compare NEOG & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$11.22

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$13.70

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEOG
WVE
Founded
1981
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
NEOG
WVE
Price
$11.22
$13.70
Analyst Decision
Buy
Strong Buy
Analyst Count
4
16
Target Price
$10.67
$30.44
AVG Volume (30 Days)
2.6M
2.2M
Earning Date
04-10-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$894,661,000.00
$3,704,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.67
$15.93
P/E Ratio
$124.89
N/A
Revenue Growth
N/A
149.43
52 Week Low
$3.87
$5.28
52 Week High
$11.43
$21.73

Technical Indicators

Market Signals
Indicator
NEOG
WVE
Relative Strength Index (RSI) 68.60 50.01
Support Level $10.37 $12.53
Resistance Level N/A $14.56
Average True Range (ATR) 0.35 0.77
MACD -0.06 0.19
Stochastic Oscillator 80.03 40.20

Price Performance

Historical Comparison
NEOG
WVE

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: